Reuters Health Report

Click to View in Browser 05/13/2014 GSK says heart drug darapladib fails in second late-stage trial LONDON (Reuters) - GlaxoSmithKline said its drug darapladib had not reduced heart attacks or other major events in patients with acute coronary syndrome, marking another disappointment for the innovative heart medicine. Gene Signal in talks for a partner for eye disease drug ZURICH (Reuters) - Gene Signal is in talks with potential partners to help develop its new treatment for a leading cause of blindness in the elderly, the biotech firm's chief executive said on Tuesday. Haitian orphan gets nation's first 3-D printer prosthesis PORT-AU-PRINCE (Reuters) - A 12-year-old orphan boy handicapped from birth became the first recipient of a 3-D printer prosthesis in Haiti last month, thanks to a British-born software engineer in California. Wine compound not tied to improved health: study NEW YORK (Reuters Health) - A compound found in wine and chocolate may not be linked to improved health as was once claimed, according to a new study. Complications rare with baby circumcisions, rise with age (Reuters Health) - There are few reported complications after boys are circumcised during their first year of life, but the risk rises considerably if the procedure is performed later in childhood, according to a new analysis published on Monday. Bullying linked to increased inflammation: study NEW YORK (Reuters Health) - Researchers already know that many kids who are bullied appear to suffer socially, psychologically and even physically years later. According to a new study, the physical consequences might be explained by an increase in low-grade inflammation throughout the body. UK health authorities say second U.S. MERS case flew via London LONDON (Reuters) - British health authorities said on Monday they had found a second case of the deadly Middle East Respiratory Syndrome (MERS) virus in a person transiting through London, who flew from Jeddah in Saudi Arabia to the United States on May 1. Arthritis, lupus and asthma data a shot in arm for AstraZeneca LONDON (Reuters) - AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as four experimental drugs for rheumatoid arthritis, lupus and asthma showed promising results in mid-stage clinical trials. U.S. health secretary nominee faces second Senate hearing May 14 WASHINGTON (Reuters) - Sylvia Mathews Burwell, President Barack Obama's nominee for U.S. health secretary, will face a second confirmation hearing on Wednesday before the Senate Finance Committee, the panel announced on Monday. Valeant says plans to "improve" offer for Allergan (Reuters) - Valeant Pharmaceuticals International Inc VRX.TO said on Tuesday it will "improve" its $47 billion takeover offer for drugmaker Allergan Inc AGN.N, a day after the U.S. company rejected the bid. Related Video Study links leadership and alcohol in zebrafish Mid-May brings heavy snowfall to Denver The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend